A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
NFKBIA has the Capacity to Serve as a Diagnostic Biomarker for Prostate Cancer Patient
[post]
2020
unpublished
Background: Prostate cancer is the the second leading cause of cancer-related death in male. NF-κB inhibitor alpha gene (NFKBIA), is found dys-expressed in the progression of tumors. The aim of this study was to investigate the expression of NFKBIA and its diagnostic value in prostate cancer patients.Methods: The mRNA expression of NFKBIA was detected with quantitative real-time polymerase chain reaction (qRT-PCR) assay and the association of its expression with clinical characteristic was
doi:10.21203/rs.3.rs-54669/v1
fatcat:4wszi67xwvahfc67d6cbuwt46q